Viracta Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cardiff, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Viracta Therapeutics, Inc. has filed 1,181 SEC EDGAR filings since 07 Aug 2002

SEC filing history

Showing 101-110 of 110 matching filings.

Per page
25
Current page
5
SC 13G/A File 005-81034

SC 13G/A

Filing date
14 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SUNESIS PHARMACEUTICALS INC 13G

Filing date
11 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

AMENDMENT NO. 3

Filing date
11 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-81034

SUNESIS PHARMACEUTICALS INC 13G

Filing date
25 Feb 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SC 13G/A filing

Filing date
16 Feb 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-81034

SC 13G

Filing date
16 Feb 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SC 13G/A filing

Filing date
16 Feb 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SCHEDULE 13G AMENDMENT NO. 1

Filing date
12 Feb 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SC 13G/A filing

Filing date
12 Feb 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SC 13G/A filing

Filing date
26 Jan 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .